Akèy › Gliyoblastòm
Etid klinik pou Gliyoblastòm ap rekrite nan Etazini
157 etid pou Gliyoblastòm ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY30 etid
- Boston, MA28 etid
- Houston, TX25 etid
- Los Angeles, CA23 etid
- Durham, NC20 etid
- San Francisco, CA17 etid
- Washington, DC15 etid
- Rochester, MN15 etid
- Chicago, IL15 etid
- Miami, FL14 etid
- Columbus, OH14 etid
- Jacksonville, FL13 etid
- Aurora, CO12 etid
- St. Louis, MO12 etid
- Atlanta, GA11 etid
- Salt Lake City, UT11 etid
- Philadelphia, PA11 etid
- Baltimore, MD11 etid
- Cleveland, OH11 etid
- Baldwin Park, CA10 etid
- Pittsburgh, PA9 etid
- Birmingham, AL9 etid
- Dallas, TX9 etid
- Nashville, TN9 etid
- Phoenix, AZ8 etid
- Winston-Salem, NC8 etid
- Seattle, WA8 etid
- San Antonio, TX8 etid
- San Diego, CA7 etid
- Edison, NJ7 etid
- Cincinnati, OH6 etid
- Tampa, FL6 etid
- Madison, WI6 etid
- Ann Arbor, MI6 etid
- Lexington, KY5 etid
- Mountain View, CA5 etid
- Queens, NY5 etid
- Omaha, NE5 etid
- Arlington, VA5 etid
- Charlottesville, VA5 etid
Pa eta
- Alabama9 etid
- Arizona13 etid
- Colorado14 etid
- Connecticut5 etid
- Distrik Columbia9 etid
- Florid30 etid
- Georgia12 etid
- Illinois16 etid
- Indiana4 etid
- Iowa4 etid
- Kalifòni40 etid
- Kansas3 etid
- Kentucky5 etid
- Maryland16 etid
- Massachusetts29 etid
- Michigan11 etid
- Minnesota19 etid
- Missouri12 etid
- Nebraska5 etid
- New Jersey8 etid
- New York33 etid
- North Carolina26 etid
- Ohio23 etid
- Oklahoma4 etid
- Pennsylvania21 etid
- Rhode Island3 etid
- South Carolina3 etid
- Tennessee10 etid
- Texas33 etid
- Utah11 etid
- Virginia10 etid
- Washington9 etid
- Wisconsin8 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06991101Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05432804A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT03970447GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07301268GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Ap rekriteFaz 1
Laj 21 a 70 · Tout sèks · Mizajou Sep 30, 2026 · NCT06815432The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07285044Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05902169Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07326566A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05303467Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Ap rekriteFaz 1/2
Laj 18 a 99 · Tout sèks · Mizajou Sep 28, 2026 · NCT07416188Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07145112A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Ap rekriteFaz 1/2
Jiska laj 25 · Tout sèks · Mizajou Sep 25, 2026 · NCT04094610Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07195591MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT03896568Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06047379RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
Ap rekriteFaz 1
Laj 18 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT06389591OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
Ap rekriteFaz 2
Laj 18 a 90 · Tout sèks · Mizajou Sep 23, 2026 · NCT06558214Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Ap rekriteFaz 1/2
Laj 18 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT06814496A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT05765812Anti-GD2 ADC M3554 in Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06641908VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
Ap rekriteFaz 2
Laj 18 a 98 · Tout sèks · Mizajou Sep 21, 2026 · NCT07831369REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07831772Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT04977375ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07089641A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Ap rekriteFaz 1
Laj 19 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05698524Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.